AGAPE ATP CORPORATION Other Accounts Payable and Accrued Liabilities
AGAPE ATP CORPORATION (ATPC) had Other Accounts Payable and Accrued Liabilities of $710.80 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Payables and Accruals
us-gaap:OtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- 2026-06-30: Other Accounts Payable and Accrued Liabilities $710.80K.
- 2026-03-31: Other Accounts Payable and Accrued Liabilities $674.96K.
- 2025-12-31: Other Accounts Payable and Accrued Liabilities $768.78K; Other Accounts Payable and Accrued Liabilities as first filed $794.91K.
- 2025-09-30: Other Accounts Payable and Accrued Liabilities $600.10K.
| Period end | Other Accounts Payable and Accrued Liabilities | Other Accounts Payable and Accrued Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $710.80K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $674.96K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $768.78K 10-Q · filed 2026-08-14 | $794.91K 10-K · filed 2026-04-13 |
| 2025-09-30 | $600.10K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $567.11K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $631.65K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $712.44K 10-K · filed 2026-04-13 | |
| 2024-09-30 | $540.90K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $507.06K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $535.25K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $726.06K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $479.43K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $475.67K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $586.67K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $713.28K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $616.31K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $637.03K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $742.44K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $858.36K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $508.13K 10-Q/A · filed 2022-07-05 | |
| 2021-06-30 | $505.55K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $580.29K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $647.68K 10-Q/A · filed 2022-07-05 | |
| 2020-09-30 | $464.81K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $467.57K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $97.46K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $77.25K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $123.29K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $32.32K 10-K · filed 2020-03-27 | $110.59K 10-K · filed 2019-09-13 |
| 2019-03-31 | $8.84K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $7.88K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $7.75K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $19.75K 10-K/A · filed 2019-12-02 | |
| 2018-03-31 | $2.00K 10-Q/A · filed 2018-06-19 | |
| 2017-12-31 | $2.00K 10-Q · filed 2018-02-13 | |
| 2017-06-30 | $8.00K 10-K · filed 2018-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |